Axa’s Parexel International Corp PRXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-12,797
Closed -$808K 1341
2017
Q1
$808K Sell
12,797
-23,980
-65% -$1.59M ﹤0.01% 973
2016
Q4
$2.42M Buy
+36,777
New +$2.31M 0.01% 729
2016
Q3
Sell
-97,700
Closed -$6.14M 1422
2016
Q2
$6.14M Buy
+97,700
New +$6.05M 0.03% 523
2015
Q4
Sell
-17,680
Closed -$1.09M 1549
2015
Q3
$1.09M Sell
17,680
-106,042
-86% -$7.13M ﹤0.01% 894
2015
Q2
$7.96M Buy
123,722
+7,822
+7% +$527K 0.03% 468
2015
Q1
$8M Sell
115,900
-4,900
-4% -$312K 0.03% 448
2014
Q4
$6.71M Buy
120,800
+115,560
+2,205% +$6.67M 0.03% 481
2014
Q3
$331K Sell
5,240
-5,200
-50% -$296K ﹤0.01% 1153
2014
Q2
$552K Hold
10,440
﹤0.01% 1045
2014
Q1
$565K Sell
10,440
-10,418
-50% -$534K ﹤0.01% 1045
2013
Q4
$942K Sell
20,858
-2,500
-11% -$114K ﹤0.01% 933
2013
Q3
$1.17M Buy
23,358
+20,858
+834% +$1.02M 0.01% 843
2013
Q2
$115K Buy
+2,500
New +$110K ﹤0.01% 1146

Other funds holding PRXL

Axa's PRXL Position: Q2 2017 in Review

Axa sold out of Parexel International Corp (PRXL) in Q2 2017, closing a stake of 12,797 shares — an estimated $808K sold.

Axa first reported a position in PRXL in Q2 2013 and held it in 13 quarters. The position peaked at $8M in Q1 2015. 311 funds tracked by Wall St. Rank hold PRXL as of Q2 2017.

  • Axa reported no remaining Parexel International Corp position as of Q2 2017 after selling out during the quarter.
  • Axa sold 12,797 Parexel International Corp shares in Q2 2017, an estimated $808K.
  • Axa first reported a position in Parexel International Corp in Q2 2013 and held it in 13 quarters.
  • Axa's Parexel International Corp position peaked at $8M in Q1 2015.
  • 311 funds tracked by Wall St. Rank held Parexel International Corp as of Q2 2017.

Based on Axa's 13F filing for Q2 2017, filed 10 Aug 2017.